Can a Billionaire's Son Spend His Way to a House Seat in New York? - The New York Times
Regeneron CEO hopes to have coronavirus treatment made near August
Entrepreneur of the Year shows power of persistence | Cornell Chronicle
Regeneron CEO Leonard Schleifer '73 Involved in Trump Experimental COVID-19 Treatment | The Cornell Daily Sun
Chapel Haven Schleifer Center, Inc. opens new chapter! – Chapel Haven
Leonard Schleifer - Society for Science
College admissions scam prosecutor benefited from his own life of privilege
Regeneron CEO Schleifer, chief scientist Yancopoulos bag massive $270M payday | Fierce Pharma
Leonard Schleifer - YouTube
Biotech executives pull in some of health care's biggest paydays
A new DNA Learning Center at Regeneron - Cold Spring Harbor Laboratory
Pharma CEOs in Shouting Match Over Prices: 'It's Ridiculous' - Bloomberg
Q&A: Regeneron Founder – and UVA M.D./Ph.D. Alum – Discusses COVID-19 Treatment | UVA Today
Leonard S. Schleifer, MD, PhD – UVA Medical Alumni Association
Regeneron on Twitter: "Congrats to our Prez and CEO (& @uvamedalum) Len Schleifer for being recognized with the Walter Reed Distinguished Achievement Award for his leadership and commitment to innovation: https://t.co/FGHkql59Ng https://t.co/TDmiPnqz2u" /
Meet the Billionaires Behind Regeneron, Who Made Trump's COVID-19 Drug
Leonard S. Schleifer - Founder, President, and Chief Executive Officer @ Regeneron - Crunchbase Person Profile
Drug Maker in High-Stakes Race With Rivals - WSJ
Is pharma's biggest internal critic risking a reckoning? - STAT
Len Schleifer and George Yancopoulos - Cold Spring Harbor Laboratory
Transcript: Regeneron CEO Leonard Schleifer on "Face the Nation," October 11, 2020 - CBS News
Leonard Schleifer - STAT
Leonard Schleifer - STAT
Regeneron CEO Leonard Schleifer in Boston: drug pricing could be 'the undoing of our industry' - Boston Business Journal
SPOTLIGHT! HARRIET AND LEONARD SCHLEIFER | Jewish Federation of Greater New Haven
Regeneron CEO's pay drops 95%—but that shouldn't come as a shock | Fierce Pharma
Regeneron CEO: Trump's Use of Drug 'Weakest Evidence' of Any Success
